SCHEMBL17258376

SCHEMBL17258376

Cc1ccc(S(=O)(=O)OCc2cccc(CN=[N+]=[N-])n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
HTR6 P50406 1/20 0.33
STAT3 P40763 1/20 0.33
ESR1 P03372 1/20 0.33
GAA P10253 1/20 0.33
ESR2 Q92731 1/20 0.33
VDR P11473 1/20 0.33
C5AR1 P21730 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA9 Q16790 1/20 0.32
CD4 P01730 1/20 0.32
LMNA P02545 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25318427 0.87 KEAP1 (0.44) ALDH1A1HPGDKDM4EKEAP1NFE2L2
SCHEMBL17258357 0.81 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL16050463 0.80 KEAP1 (0.40) ALDH1A1HPGDKDM4EKEAP1NFE2L2
SCHEMBL16050461 0.78 KEAP1 (0.38) ALDH1A1HPGDKDM4EKEAP1NFE2L2
SCHEMBL3645222 0.78 KEAP1 (0.40) ALDH1A1HPGDKDM4EKEAP1NFE2L2
SCHEMBL16050543 0.76 PSMD10 (0.39) ALDH1A1HPGDKDM4EKEAP1NFE2L2
SCHEMBL30400479 0.75 KDM4E (0.37) ALDH1A1KDM4ELMNA
SCHEMBL17768577 0.75 KDM4E (0.37) ALDH1A1KDM4ELMNA
SCHEMBL15445196 0.75 GAA (0.42) ALDH1A1HPGDKDM4ESTAT3GAA
SCHEMBL15259719 0.74 HRH4 (0.47) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9469656-B2 HDAC inhibitors as anti-cancer agents THE UNIVERSITY OF TOLEDO (US) 2016-10-18 US disclosed
US-20150329560-A1 HDAC Inhibitors as Anti-Cancer Agents THE UNIVERSITY OF TOLEDO (US) 2015-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329560-A1 HDAC Inhibitors as Anti-Cancer Agents HDAC1, HDAC4, HDAC5 ALDH1A1 1221/4885HPGD 1311/4885KDM4E 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.